Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/18/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Alberto Giovanni Aleotti

Wrong Dr. Alberto Giovanni Aleotti?

Board Member

Company Description: Thanks to the continuous attention given to this important goal of service which has witnessed Menarini commit itself over the years to informing physicians on some...   more

Employment History

Board Memberships and Affiliations

21 Total References
Web References
Commenting on the deal, Alberto ..., 18 June 2013 [cached]
Commenting on the deal, Alberto Giovanni Aleotti, Vice Chairman of Menarini Group said: "We are delighted and honored to further strengthen our long-term partnership with Gilead to help address the needs of angina patients in these new territories, in particular the Asia Pacific region."
Alberto Giovanni Aleotti, a ..., 1 Dec 2012 [cached]
Alberto Giovanni Aleotti, a member of Menarini's board of directors, adds, "we are eager to start our collaboration with OBT, an oncology company with a proven track record of generating innovative antibody-based cancer drug candidates that are designed to address high unmet medical needs.
October 20th 2009 - ADENURIC® / 2009 / News Archive / News / Menarini - Menarini, 20 Oct 2009 [cached]
" Research in new treatments for gout has been absent for nearly forty years, making it an orphan disease in some respects" declared Dr. Alberto Aleotti, Chairman and Chief Executive Officer of the Menarini Group " We are therefore extremely proud that Ipsen has chosen Menarini as the ideal partner to substantially contribute to European patients' health with an innovative drug in this therapeutic area".
Alberto Giovanni Aleotti, ..., 8 Mar 2013 [cached]
Alberto Giovanni Aleotti, member of the Board of A. Menarini, commented, "Working with OBT is a fantastic opportunity, and Menarini believe that alliances like this should be embraced on a wider scale to ensure that novel and targeted therapies are brought to market efficiently, with the ultimate aim always of providing the best treatment options possible to healthcare professionals and their patients."
Alberto Giovanni Aleotti, ..., 14 May 2012 [cached]
Alberto Giovanni Aleotti, Member of the Board of Menarini Group stated, "Priligy® is an innovative drug and the only product that has received regulatory approval specifically for the treatment of premature ejaculation.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.